Endpoint definition
↥
FinnGen phenotype data
Filter registries None
Check pre-conditions None
Check conditions None
Apply sex-specific rule None
Extra metadata
First used in FinnGen datafreeze
DF2
Filter registries None
Check pre-conditions None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to
Co-morbidites, CVD and metabolic diseases
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 90966 | 40372 | 50594 |
Unadjusted prevalence (%) | 34.98 | 27.47 | 44.74 |
Mean age at first event (years) | 56.93 | 56.52 | 57.26 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.06 | 5.09 [4.75, 5.44] | <1e-100 | 16390 |
15 years | 0.03 | 6.40 [5.99, 6.84] | <1e-100 | 13559 |
5 years | 0.01 | 10.21 [9.33, 11.18] | <1e-100 | 5947 |
1 year | 0.00 | 23.92 [20.09, 28.48] | <1e-100 | 2694 |
Index endpoint: ASTHMA_CVDMETABOCOMORB – Co-morbidites, CVD and metabolic diseases
GWS hits:
before Co-morbidites, CVD and metabolic diseases
after Co-morbidites, CVD and metabolic diseases
Loading survival analyses plot
Loading survival analyses table